Shenzhen Edge Medical Co (FRA:R5Z) Other Current Receivables: €1.59 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:R5Z Shenzhen Edge Medical Co Ltd FRA:R5Z
20 GF Score
Price €4.13
! 3 Warning Signs
View Full Analysis

What is Shenzhen Edge Medical Co Other Current Receivables?

Shenzhen Edge Medical Co FRA:R5Z -0.96% 20 Other Current Receivables is €1.59 Mil as of Dec. 2025. GuruFocus rates FRA:R5Z with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Shenzhen Edge Medical Co's Other Current Receivables for the quarter that ended in Dec. 2025 was €1.59 Mil.

Shenzhen Edge Medical Co's quarterly Other Current Receivables increased from Dec. 2024 (€1.60 Mil) to Jun. 2025 (€2.54 Mil) but then stayed the same from Jun. 2025 (€2.54 Mil) to Dec. 2025 (€1.59 Mil).

Shenzhen Edge Medical Co's annual Other Current Receivables increased from Dec. 2023 (€0.19 Mil) to Dec. 2024 (€1.60 Mil) but then declined from Dec. 2024 (€1.60 Mil) to Dec. 2025 (€1.59 Mil).

Shenzhen Edge Medical Co Other Current Receivables Related Terms

Shenzhen Edge Medical Co Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Shenzhen Edge Medical Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Edge Medical Co Other Current Receivables Chart

Shenzhen Edge Medical Co Annual Data
Trend Dec23 Dec24 Dec25
Other Current Receivables
0.19 1.60 1.59

Shenzhen Edge Medical Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables 0.19 0.00 1.60 2.54 1.59
FRA:R5Z
20GF Score
Shenzhen Edge Medical Co Ltd FRA:R5Z
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Edge Medical Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €1.59 Mil mean?
Shenzhen Edge Medical Co (FRA:R5Z) has a Other Current Receivables of €1.59 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Shenzhen Edge Medical Co and its competitors.
Is Shenzhen Edge Medical Co's Other Current Receivables too high?
Shenzhen Edge Medical Co's current Other Current Receivables is €1.59 Mil. Overall, Shenzhen Edge Medical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's Other Current Receivables compare to ABT and SYK?
Shenzhen Edge Medical Co's Other Current Receivables of €1.59 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Shenzhen Edge Medical Co and its competitors. Shenzhen Edge Medical Co's current Other Current Receivables is €1.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (FRA:R5Z) has a current Other Current Receivables of €1.59 Mil. The current Other Current Receivables is €1.59 Mil. Shenzhen Edge Medical Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Shenzhen Edge Medical Co (FRA:R5Z), the current Other Current Receivables is €1.59 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shenzhen Edge Medical Co Business Description

Other Exchanges 02675:Hong Kong
Address Baolong Street, Room 1901, Building 2B, Smart Park Phase II, Longgang District, Shenzhen, CHN
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
20GF Score

Get the complete analysis for FRA:R5Z

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.13
Price